The isoprostane 8‐iso‐PGF2αstimulates endothelial cells to bind monocytes: difference to thromboxane‐mediated endothelial activation
- 12 March 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (7) , 1254-1256
- https://doi.org/10.1096/fj.00-0498fje
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Fund (P13954-MED)
This publication has 55 references indexed in Scilit:
- The isoprostane, 8-epi-PGF2α, is accumulated in coronary arteries isolated from patients with coronary heart diseaseCardiovascular Research, 1999
- Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human PlateletsPublished by Elsevier ,1999
- Prostaglandin F2-Like Compounds, F2-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Intracellular Signaling by 8-epi-Prostaglandin F2αIs Mediated by Thromboxane A2/Prostaglandin Endoperoxide Receptors in Porcine Carotid ArteriesBiochemical and Biophysical Research Communications, 1996
- Molecular mechanisms of diverse actions of prostanoid receptorsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitusFEBS Letters, 1995
- Stimulatory Effect of 8-Epi-PGF2α, An F2-Isoprostane, on Endothelin-1 ReleaseJournal of Cardiovascular Pharmacology, 1995
- Formation of F2‐isoprostanes during aortic endothelial cell‐mediated oxidation of low density lipoproteinFEBS Letters, 1994
- Formation of PGF2-Isoprostanes During the Oxidative Modification of Low Density LipoproteinBiochemical and Biophysical Research Communications, 1994
- Vascular Smooth Muscle Actions and Receptor Interactions of 8-Iso-prostaglandin E2, an E2-IsoprostaneBiochemical and Biophysical Research Communications, 1993